focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Share News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ergomed trading in line after solid first half

Tue, 25th Jul 2023 10:14

(Sharecast News) - Pharmaceutical service specialist Ergomed descried a robust first-half performance in an update on Tuesday, as well as a positive outlook for the future.

The AIM-traded company said revenue in the first six months of the year totalled £76.7m - up 10% year-on-year, or 7% at constant currency.

It said its clinical research services (CRO) business played a significant role in that growth, as it experienced an 11% increase in revenue to £38m.

Additionally, PrimeVigilance - its pharmacovigilance (PV) business - experienced 9% revenue growth, to £38.7m.

As at 30 June, Ergomed boasted a cash position of £26m, improving from £12m at the same point in 2022.

The firm said its underlying operating cash flow generation during the time was positive.

Additionally, Ergomed said it remained debt-free, and held unused facilities totalling £80m, which could be leveraged to support further organic expansion and acquisitions.

Looking ahead, Ergomed said it expected its revenue and adjusted EBITDA for the full year would be in line with market expectations.

"Ergomed has made a very solid start to the year demonstrating continued growth, reflecting the resilience of the markets we operate in, our services-based business model, and the global appeal of our offering to our clients," said executive chairman Dr Miroslav Reljanović.

"We continue to execute on our strategy to transform the business by investing in technology and our commercial infrastructure which has been reflected in robust year over year growth of our new business pipeline.

Dr Reljanović said that additionally, Ergomed was focussing on prudent cost management and executing its "disciplined approach" to mergers and acquisitions.

"We expect to deliver on our expectations for financial results for 2023, and we look forward with confidence to the rest of this year and beyond."

Ergomed said it would report its interim results for the first half of 2023 in September.

At 1031 BST, shares in Ergomed were up 3.17% at 1,075p.

Reporting by Josh White for Sharecast.com.

More News
16 May 2019 13:02

Thursday broker round-up

(Sharecast News) - Grainger: Numis downgrades to add with a target price of 295p.

Read more
16 May 2019 10:52

Ergomed Shares Rise As 2019 Earnings Set To Beat Market Expectations

LONDON (Alliance News) - Shares in Ergomed PLC rose on Thursday as it said it expects earnings and revenue for 2019 to be above market expectations.Shares in the pharmaceutical services 14%

Read more
16 May 2019 09:05

Ergomed sees FY earnings 'materially ahead' of market expectations

(Sharecast News) - Ergomed said on Thursday that full-year revenue and earnings are set to be "materially" ahead of current market expectations following strong trading year-to-date.

Read more
23 Apr 2019 10:33

Three AIM firms celebrate Queen's Award for Enterprise wins

(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all picking up the accolades.

Read more
10 Apr 2019 13:12

Ergomed Outlook Confident Despite Significantly Widened Loss In 2018

LONDON (Alliance News) - Ergomed PLC on Wednesday said its loss widened sharply in 2018 due to a 42% increase in operating expenses.The clinical development company reported pretax loss of

Read more
3 Apr 2019 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 4 April Entertainment OneQ3 ResultsSmart Metering SystemsFull Year Year Year 5 8

Read more
1 Apr 2019 12:30

Ergomed Hires Former TFS Executive As Chief Commercial Officer

LONDON (Alliance News) - Pharmaceutical services provider Ergomed PLC said on Monday it has appointed Roy Ovel as chief commercial officer with immediate effect.In his new role, Ovel will a

Read more
1 Apr 2019 08:46

Ergomed taps former TFS executive for chief commercial officer

(Sharecast News) - Pharmaceutical services firm Ergomed appointed former TFS International global sales and marketing head Roy Ovel as its next chief commercial officer on Monday.

Read more
11 Mar 2019 14:03

Ergomed Reports Death Of Non-Executive Director Chris Collins

LONDON (Alliance News) - Drug development services firm Ergomed PLC on Monday said Non-Executive Director Chris Collins died on Friday last week.Collins had been on the company's board

Read more
13 Feb 2019 10:57

Finance Chief Stuart Jackson To Leave Ergomed To Take Up New Role

LONDON (Alliance News) - Pharmaceutical services firm Ergomed PLC on Wednesday said its Chief Financial Officer Stuart Jackson will be leaving in the summer.Jackson is to take up a new role

Read more
31 Jan 2019 14:41

Ergomed Outlook Optimistic As Expects Double-Digit 2018 Revenue Growth

LONDON (Alliance News) - Ergomed PLC on Thursday reported a 17% increase in revenue for 2018 and expressed confidence in delivering its growth targets in the year ahead.Ergomed, which helps

Read more
24 Jan 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 25 January BonmarcheTrading Statement AG BarrTrading GroupQ3 Smaller

Read more
23 Jan 2019 10:58

Ergomed Chief Executive Stephen Stamp To Depart For Health Reasons

LONDON (Alliance News) - Pharmaceutical services firm Ergomed PLC said on Wednesday Chief Executive Stephen Stamp is to step down for health reasons.While Ergomed looks for a new CEO, Stamp

Read more
2 Oct 2018 15:27

Santander UK Chief Joins Ergomed Board As Business Officer Departs

LONDON (Alliance News) - Ergomed PLC on Tuesday said it has appointed Michael Spiteri, chief digital officer of Santander UK, to its board with immediate effect.Spiteri joins the services a

Read more
19 Sep 2018 13:13

Wednesday broker round-up

(Sharecast News) - PureCircle: Kepler Cheuvreux downgrades to hold with a target price of 325p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.